Sidebar

services

Nadezda Dreizė  

Phone: +370 5 223 4415 
Email: 

ORCID
LinkedIn
ResearchGate

 
Research Interests: Molecular mechanisms of cancer cell resistance
Cellular signaling pathway regulation
Proteomic analysis (global proteome, phosphoproteome, kinome) 
Present Position: Researcher, Proteomics Centre, Institute of Biochemistry, Life Sciences Center, Vilnius University
Researcher, EMBL Partnership Institute, Life Sciences Center, Vilnius University 
Education:
 2020 - PhD in Natural Sciences (Biochemistry), Vilnius University
2015 - MSc in Biochemistry, Vilnius University
2013 - BSc in Biochemistry, Vilnius University 
Experience (Past Positions): 2019–2021 - Research assistant, Proteomics Center, Institute of Biochemistry, Life Sciences Center, Vilnius University
2019–2020 - Researcher, UAB Nabelita
2017–2018 - Specialist, Clinic of Gastroenterology, Nephro-Urology and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University 
Publications: LABT_LMAVB 
GoogleScholar

Projects and Grants:

2020–2023 - “Center for genetical modelling of laboratory animals” (01.2.2-CPVA-K-703-03-0032); project executor.
2020–2021 - “Development of Novel Proteomics-based Drug Selection Approach for Pancreatic Cancer Individualized Therapy” (DiaKasa2; S-SEN-20-16); project executor.
2018–2021 - “Development of Primary Cell Cultures Technologies for the Increased Efficacy of Chemotherapy" (J05-LVPA-K-03-0080); project executor.
2016–2018 - “New Multifunctional Nanobiosensor for Early Pancreatic Cancer Diagnostics” (DiaKASA SEN-01/2016); project executor.
2015–2018 - “Novel Biomarkers for Individualized Therapy of Colon Cancer: Proteomics, Micrornomics and Clinics” (PROMa; SEN-17/2015); project executor.
2014–2016 - “High Throughput Proteomics for Cancer Cell Surface Protein Recognition by Quantum Dots” (SUREDOT; MIP-033/2014); project executor.
Languages: Lithuanian (native), English, Russian

 

Research